Readmission Due to Exacerbation of COPD: Associated Factors

Lajas, Alicia Cerezo; Gutiérrez‐González, Enrique; Parrado, César Llorente; Miguel-Díez, Javier de

doi:10.1007/s00408-018-0093-y

Cited by 13 publications

(4 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…21 Males, based on review and retrospective study, in accordance with our estimates, had a higher frequency of readmission. 44,45 Because females were less likely to self-report COPD and have COPD as a primary diagnosis, when women were readmitted within 30 days their reasons for readmission may not have been caused by COPD.…”

Section: Discussionmentioning

confidence: 99%

<p>Multi-morbidities are Not a Driving Factor for an Increase of COPD-Related 30-Day Readmission Risk</p>

Lin

Xue

Deng

et al. 2020

COPD

View full text Add to dashboard Cite

Background and Objective: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death in the United States. COPD is expensive to treat, whereas the quality of care is difficult to evaluate due to the high prevalence of multi-morbidity among COPD patients. In the US, the Hospital Readmissions Reduction Program (HRRP) was initiated by the Centers for Medicare and Medicaid Services to penalize hospitals for excessive 30-day readmission rates for six diseases, including COPD. This study examines the difference in 30-day readmission risk between COPD patients with and without comorbidities. Methods: In this retrospective cohort study, we used Cox regression to estimate the hazard ratio of 30-day readmission rates for COPD patients who had no comorbidity and those who had one, two or three, or four or more comorbidities. We controlled for individual, hospital and geographic factors. Data came from three sources: Healthcare Cost and Utilization Project (HCUP) State Inpatient Databases (SID), Area Health Resources Files (AHRF) and the American Hospital Association's (AHA's) annual survey database for the year of 2013. Results: COPD patients with comorbidities were less likely to be readmitted within 30 days relative to patients without comorbidities (aHR from 0.84 to 0.87, p < 0.05). In a stratified analysis, female patients with one comorbidity had a lower risk of 30-day readmission compared to female patients without comorbidity (aHR = 0.80, p < 0.05). Patients with public insurance who had comorbidities were less likely to be readmitted within 30 days in comparison with those who had no comorbidity (aHR from 0.79 to 0.84, p < 0.05). Conclusion: COPD patients with comorbidities had a lower risk of 30-day readmission compared with patients without comorbidity. Future research could use a different study design to identify the effectiveness of the HRRP.

show abstract

Section: Discussionmentioning

confidence: 99%

<p>Multi-morbidities are Not a Driving Factor for an Increase of COPD-Related 30-Day Readmission Risk</p>

Lin

Xue

Deng

et al. 2020

COPD

View full text Add to dashboard Cite

show abstract

“…We developed a step-wise detailed search strategy. Four main key terms (COPD, readmission, risk factors and consequences) were developed as 'concepts' based on reviewing the previous systematic review and studies relevant to the topic [19,22]. Detailed alternative terms and synonyms for each of the key concepts were also identified as free-text terms and used to search in the databases as title and abstract.…”

Section: Search Strategymentioning

confidence: 99%

Risk factors and associated outcomes of hospital readmission in COPD: A systematic review

Njoku

Alqahtani

Wimmer

et al. 2020

Respiratory Medicine

View full text Add to dashboard Cite

show abstract

“…11 Gender, history of frequent admissions, comorbidities, and length of stay (LOS) were relevant risk factors for 30- and 90-day readmissions. 11,12 Readmitted patients mostly participate in Medicare and Medicaid and suffer from more comorbidities. 13 Obviously, 30- and 90-day COPD readmissions are common, and patients with non-COPD readmission have a greater burden of comorbidities in readmission diagnosis than those in COPD.…”

Section: Introductionmentioning

confidence: 99%

All-cause readmission rate and risk factors of 30- and 90-day after discharge in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

Ruan,

Zhao,

Wang

et al. 2023

Ther Adv Respir Dis

View full text Add to dashboard Cite

Background: The readmission rate following hospitalization for chronic obstructive pulmonary disease (COPD) is surprisingly high, and frequent readmissions represent a higher risk of mortality and a heavy economic burden. However, information on all-cause readmissions in patients with COPD is limited. Objective: This study aimed to systematically summarize all-cause COPD readmission rates within 30 and 90 days after discharge and their underlying risk factors. Methods: Eight electronic databases were searched to identify relevant observational studies about COPD readmission from inception to 1 August 2022. Newcastle-Ottawa Scale was used for methodological quality assessment. We adopt a random effects model or a fixed effects model to estimate pooled all-cause COPD readmission rates and potential risk factors. Results: A total of 28 studies were included, of which 27 and 8 studies summarized 30- and 90-day all-cause readmissions, respectively. The pooled all-cause COPD readmission rates within 30 and 90 days were 18% and 31%, respectively. The World Health Organization region was initially considered to be the source of heterogeneity. We identified alcohol use, discharge destination, two or more hospitalizations in the previous year, and comorbidities such as heart failure, diabetes, chronic kidney disease, anemia, cancer, or tumor as potential risk factors for all-cause readmission, whereas female and obesity were protective factors. Conclusions: Patients with COPD had a high all-cause readmission rate, and we also identified some potential risk factors. Therefore, it is urgent to strengthen early follow-up and targeted interventions, and adjust or avoid risk factors after discharge, so as to reduce the major health economic burden caused by frequent readmissions. Trial registration: This systematic review and meta-analysis protocol was prospectively registered with PROSPERO (no. CRD42022369894).

show abstract

Readmission Due to Exacerbation of COPD: Associated Factors

Cited by 13 publications

References 46 publications

<p>Multi-morbidities are Not a Driving Factor for an Increase of COPD-Related 30-Day Readmission Risk</p>

<p>Multi-morbidities are Not a Driving Factor for an Increase of COPD-Related 30-Day Readmission Risk</p>

Risk factors and associated outcomes of hospital readmission in COPD: A systematic review

All-cause readmission rate and risk factors of 30- and 90-day after discharge in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

Contact Info

Product

Resources

About